Download PDF
Synfacts 2020; 16(07): 0765
DOI: 10.1055/s-0040-1707019
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections

Contributor(s):
Philip Kocienski
Further Information

Publication History

Publication Date:
17 June 2020 (online)

   Permissions and Reprints

Key words

remdesivir - GS-5734 - COVID-19 - C-nucleoside - phosphoramidate prodrug - cyanation - pyrrolotriazinamine